Exogenous IL-4 and IL-13 enhanced the growth of pancreatic cancer cells [25,26], while IL-4-/IL-13-neutralizing antibodies counteracted this effect [18]. The gene discussed is IL13; the disease is familial pancreatic carcinoma.